SWOT Analysis Reports & Company Profiles

Publications found: 164,030
Sort by:

Prothena Corporation plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Prothena Corporation plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cancer Genetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cancer Genetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Jaguar Health Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jaguar Health Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Reata Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reata Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regulus Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regulus Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Affimed NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affimed NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Otonomy Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Otonomy Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PTC Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PTC Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Acceleron Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acceleron Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Adverum Biotechnologies Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adverum Biotechnologies Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

IVERIC bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

IVERIC bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pieris Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pieris Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ultragenyx Pharmaceutical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ultragenyx Pharmaceutical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

DarioHealth Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

DarioHealth Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Flex Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Flex Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Fortress Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fortress Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NantKwest Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NantKwest Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caredx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caredx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Crispr Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Crispr Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Foamix Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Foamix Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Intercept Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intercept Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Recro Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Recro Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aptevo Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aptevo Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sesen Bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sesen Bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NanoString Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NanoString Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SCYNEXIS, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SCYNEXIS, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

vTv Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

vTv Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Argos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Argos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

INC Research Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

INC Research Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Proteostasis Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proteostasis Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TRACON Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TRACON Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Corbus Pharmaceuticals Holding Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Corbus Pharmaceuticals Holding Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Enanta Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Enanta Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Epizyme Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Epizyme Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AC Immune Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AC Immune Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Veracyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Veracyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Horizon Pharma PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Horizon Pharma PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Retrophin Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Retrophin Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Supernus Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Supernus Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Adaptimmune Therapeutics Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adaptimmune Therapeutics Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Clearside Biomedical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clearside Biomedical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Organovo Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Organovo Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CytomX Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CytomX Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Insys Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Insys Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Miragen Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Miragen Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Onconova Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Onconova Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AcelRx Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AcelRx Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alder BioPharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alder BioPharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ChemoCentryx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ChemoCentryx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Fate Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fate Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

7,665
6,761
4,993
4,645
4,328
4,036
3,979
3,241
3,083
2,925
2,713
2,595
2,125
2,024
2,008
1,654
1,587
1,254
1,158
1,091
982
791
789
572
494
493
304
1,542
9,254
3,983
67,744
8,589
1,186
3,442

Publishers

53,883
43,113
1,245
3
12
1
5
4
2
2
9
11,951
6
5
12,341
6
3
11,044
12
27
48
6
356
24,220
1
1,042
7
1
1,225
1,830
3
149
352
4
2
2
517
1
60

Regions

171
94
91
91
83
80
54
43
34
32
30
19
18
17
13
12
12
12
11
6
5
5
5
5
4
4
4
4
4
4
3
2
2
2
2
2
2
2
1
470
3
1
1
1
4,304
584
433
18
12
121
9
20
12
1
66
7
1
1,007
32
19
38
40
1
154
20
506
178
28,201
65
240
189
30
630
191
163
299
18
413
48
1,433
634
14
100
23
1,445
1
32
398
1
35
41
322
217
19
23
440
8
1
10
355
671
465
429
3,775
925
8,253
1,134
3
2,843
1,162
4
1
2
3,375
1,390
996
272
798
695
402
2,433
1,099
9,272
120
1,012
4,876
884
503
2
1,712
87
2
167
16
8,662
1,193
80
5,494
313
2,376
707
135
1
4
12
3
42,543
7,541

Price

—

Date

—

Pages

—

Offers